Moderna says its vaccine is effective half a year after vaccination

The American company "Moderna" announced the effectiveness of its vaccine against Corona virus, even after half a year of vaccination with it.

The company indicated that the effectiveness of its vaccine after half the year of vaccination is 90%, and against serious cases of Corona virus 95%, according to a statement issued after the initial clinical trials.

These data would allow Moderna to obtain the full license from the US authorities in place of the limited license that the vaccine currently enjoys.

The company is conducting vaccine trials on adolescents between the ages of 12 and 17 in the United States, which include more than 3,000 people.

Moderna is also planning to conduct trials on children between the ages of 6 months and 11 years.

The company's data indicate that its vaccine increases the level of antibodies while testing additional doses to fight specific copies of the Corona virus.

Source: Novosti